Biohaven Pharma says treatment for acute migraine succeeds in study
Biohaven Pharmaceutical Holding Company Ltd said on Tuesday two doses of its experimental treatment for… Read More
6 years ago
migraine
Migraine is the third most common disease in the world: Study
Migraine Awareness Week is going on this week and according to a survey, an alarming… Read More
7 years ago
Biohaven tumbles as migraine drug efficacy fails to impress investors
Biohaven Pharmaceutical Holding said its migraine treatment met the main goals in two late-stage studies… Read More
7 years ago